
Sign up to save your podcasts
Or


Today we'll discuss an important trial on febuxostat (ulloric), which raises important concerns about its safety from a cardiovascular perspective. Be sure to tune in to the #RheumJC discussion that will be happening this Thursday!
By Michael Putman4.9
113113 ratings
Today we'll discuss an important trial on febuxostat (ulloric), which raises important concerns about its safety from a cardiovascular perspective. Be sure to tune in to the #RheumJC discussion that will be happening this Thursday!

323 Listeners

499 Listeners

876 Listeners

131 Listeners

1,146 Listeners

121 Listeners

192 Listeners

172 Listeners

67 Listeners

247 Listeners

4 Listeners

183 Listeners

11 Listeners

18 Listeners

6 Listeners